Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders

Vaccine

Volumn 27, Issue 33, 2009, Pages 4447-4451

  Sarkar Tyson, Mitali ^a   Smither, Sophie J ^a   Harding, S V ^a   Atkins, Timothy P ^a   Titball, Richard W ^b  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b School of Biosciences   (United Kingdom)

Author keywords

Burkholderia mallei; Burkholderia pseudomallei; Burkholderia thailandensis; Glanders; Melioidosis; Vaccine

Indexed keywords

BACTERIAL VACCINE; INACTIVATED VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BURKHOLDERIA; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; BURKHOLDERIA THAILANDENSINS; CONTROLLED STUDY; CROSS REACTION; DISEASE MODEL; DRUG EFFICACY; FEMALE; GLANDERS; HEATING; IMMUNITY; IMMUNIZATION; MELIOIDOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; FEMALE; GLANDERS; HOT TEMPERATURE; MELIOIDOSIS; MICE; MICE, INBRED BALB C; VACCINES, INACTIVATED;

EID: 67649449244     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.05.040     Document Type: Article

References (43)

1. Batchelor B.I., Paul J., Trakulsomboon S., Mgongo M., and Dance D.A. Melioidosis survey in Kenya. Trans R Soc Trop Med Hyg 88 2 (1994) 181
2. Dance D.A. Meliodosis. Rev Med Microbiol 1 (1990) 143-150
3. Yabuuchi E., and Arakawa M. Burkholderia pseudomallei and melioidosis: be aware in temperate area. Microbiol Immunol 37 11 (1993) 823-836
4. Chen Y., Peng C., Hwang K., Tsai J., Lu P., and Chen T. An indigenous Melioidosis: a case report. Kaohsiung J Med Sci 15 (1999) 292-296
5. Mathew S., Perakath B., Mathew G., Sitaram V., Nair A., Lalitha M., et al. Surgical presentation of melioidosis in India. Natl Med J India 12 2 (1999) 59-61
6. Beeker A., Van de Stadt K., Bakker K., and Melioidosis. Neth J Med 54 (1999) 76-79
7. Brett P., and Woods D. Pathogenesis of and immunity to melioidosis. Acta Tropica 74 (2000) 201-210
8. Howe C., Sampath A., and Spotnitz M. The pseudomallei Group: A review. J Infect Dis 124 6 (1971) 598-606
9. Leelarasamee A., Bovornkitti S., and Melioidosis:. A review and update. Rev Inf Dis 11 3 (1989) 413-425
10. Dance D.A.B. Melioidosis-the tip of the iceberg. Clin Microbiol Rev 4 1 (1991) 52-60
11. Puthucheary S., Parasakthi N., and Lee M.K. Septicaemic melioidosis: a review of 50 cases from Malaysia. Trans R Soc Trop Med Hyg 86 6 (1992) 683-685
12. Kim H.S., Schell M.A., Yu Y., Ulrich R.L., Sarria S.H., Nierman W.C., et al. Bacterial genome adaptation to niches: divergence of the potential virulence genes in three Burkholderia species of different survival strategies. Bmc Genomics (2005) 6
13. Gee J.E., Sacchi C.T., Glass M.B., De B.K., Weyant R.S., Levett P.N., et al. Use of 16S rRNA gene sequencing for rapid identification and differentiation of Burkholderia pseudomallei and b. mallei. J Clin Microbiol 41 10 (2003) 4647-4654
14. Smith M., Angus B., Wuthiekanun V., and White N. Arabinose assimulation defines a nonvirulent biotype of Burkholderia pseudomallei. Infect Immun 65 10 (1997) 4319-4321
15. McGilvary C.D. The transmission of glanders from horse to man. Can J Public Health 35 (1944) 268-275
16. Miller W.R., Pannell L., Cravitz L., Tanner W.A., and Ingalls M.S. Studies on Certain biological characteristics of Malleomyces mallei and Malleomyces pseudomallei. I. Morphology, cultivation, viability, and isolation from contaminated specimens. J Bacteriol 55 1 (1948) 115-126 Jan 1
17. Srinivasan A., Kraus C.N., Deshazer D., Becker P.M., Dick J.D., Spacek L., et al. Glanders in a military research microbiologist. N Engl J Med 345 4 (2001) 256-258
18. Godoy D., Randle G., Simpson A.J., Aanensen D.M., Pitt T.L., Kinoshita R., et al. Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei. J Clin Microbiol 41 5 (2003) 2068-2079
19. Brett P., and Woods D. Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugates. Infect Immun 64 7 (1996) 2824-2828
20. Brett P.J., Mah D.C., and Woods D.E. Isolation and characterization of Pseudomonas pseudomallei flagellin proteins. Infect Immun 62 5 (1994) 1914-1919
21. Charuchaimontri C., Suputtamongkol Y., Nilakul C., Chaowagul W., Chetchotisakd P., Lertpatanasuwan N., et al. Antilipopolysaccharide. II. An antibody protective against fatal melioidosis. Clin Infect Dis 29 (1999) 813-818
22. Ho M., Schollaardt T., Smith M., Perry M., Brett P., Chaowagul W., et al. Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies. Infect Immun 65 9 (1997) 3648-3653
23. Jones S.M., Ellis J.F., Russell P., Griffin K.F., and Oyston P.C.F. Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins. J Med Microbiol 51 12 (2002) 1055-1062
24. Nelson M., Prior J.L., Lever M.S., Jones H.E., Atkins T.P., and Titball R.W. Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis. J Med Microbiol 53 12 (2004) 1177-1182
25. Trevino S.R., Permenter A.R., England M.J., Parthasarathy N., Gibbs P.H., Waag D.M., et al. Monoclonal antibodies passively protect BALB/c mice against Burkholderia mallei aerosol challenge. Infect Immun 74 3 (2006) 1958-1961
26. Bryan L.E., Wong S.E., Woods D., Dance D., and Chaowagul W. Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei. Can J Infect Dis 5 (1994) 170-178
27. Germanier R., and Furer E. Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J Infect Dis 131 5 (1975) 553-558
28. Razak C.E., Ismail G., Embim N., and Omar O. Protection studies using whole cells and partially purified toxic material (PPTM) of Pseudomonas pseudomallei. Malays Appl Biol 15 2 (1986) 105-111
29. Amemiya K., Bush G.V., Deshazer D., and Waag D.M. Nonviable Burkholderia mallei induces a mixed Th1-and Th2-like cytokine response in BALB/c mice. Infect Immun 70 5 (2002) 2319-2325
30. Ulett G.C., LaBrooy J.T., Currie B.J., Barnes J.L., and Ketheesan N. A model of immunity to Burkholderia pseudomallei: unique responses following immunization and acute lethal infection. Microbes Infect 7 11-12 (2005) 1263-1275
31. Elvin S.J., Healey G.D., Westwood A., Knight S.C., Eyles J.E., and Williamson E.D. Protection against heterologous Burkholderia pseudomallei strains by dendritic cell immunization. Infect Immun 74 3 (2006) 1706-1711
32. Reed l, and Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 27 3 (1938) 493-497
33. Russell P., Eley S.M., Green M., Stagg A.J., Taylor R.R., Nelson M., et al. Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection. J Antimicrob Chemother 41 2 (1998) 301-305
34. Anuntagool N., Wuthiekanun V., White N.J., Currie B.J., Sermswan R.W., Wongratanacheewin S., et al. Short report: lipopolysaccharide heterogeneity among Burkholderia pseudomallei from different geographic and clinical origins. Am Trop Med Hyg 74 3 (2006) 348-352
35. Jeddeloh J.A., Fritz D.L., Waag D.M., Hartings J.M., and Andrews G.P. Biodefense-driven murine model of pneumonic melioidosis. Infect Immun 71 1 (2003) 584-587
36. Barnes J.L., and Ketheesan N. Development of protective immunity in a murine model of melioidosis is influenced by the source of Burkholderia pseudomallei antigens. Immunol Cell Biol 85 7 (2007) 551-557
37. Atkins T., Prior R.G., Mack K., Russell P., Nelson M., Oyston P.C.F., et al. Characterisation of an acapsular mutant of Burkholderia pseudomallei identified by signature tagged mutagenesis. J Med Microbiol 51 (2002) 539-547
38. Reckseidler S., Deshazer D., Sokol P., and Woods D. Detection of bacterial virulence genes by subtractive hybridisation: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect Immun 69 1 (2001) 34-44
39. Healey G.D., Elvin S.J., Morton M., and Williamson E.D. Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection. Infect Immun 73 9 (2005) 5945-5951
40. Haque A., Easton A., Smith D., O'Garra A., Van Rooijen N., Lertmemongkolchai G., et al. Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection. J Infect Dis 193 3 (2006) 370-379
41. Haque A., Chu K., Easton A., Stevens M.P., Galyov E.E., Atkins T., et al. A live experimental vaccine against Burkholderia pseudomallei elicits CD4(+) T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins. J Infect Dis 194 9 (2006) 1241-1248
42. Govan B., and Ketheesan N. Exposure to Burkholderia pseudomallei induces cell-mediated immunity in healthy individuals. Clin Microbiol Infect 10 6 (2004) 585-587
43. Harding S.V., Sarkar-Tyson M., Smither S.J., Atkins T.P., Oyston P.C.F., Brown K.A., et al. The identification of surface proteins of Burkholderia pseudomallei. Vaccine 25 14 (2007) 2664-2672